Prostate Cancer Archives - Baylor College of Medicine Blog Network

Baylor researchers awarded the National Academy of Sciences 2023 Cozzarelli Prize in Biomedical Sciences

March 19, 2024 Awards, Breast Cancer, Cozzarelli Prize, National Academy of Sciences, PNAS, Prostate Cancer, Research, SRC-3

The research warrants continuing investigations to translate the findings into a novel, more effective and longer-lasting cancer therapy.

Two slides showing breast cancer cells as blue or green dots on a blue background.

From The Labs

A potential strategy to control MAPK4-dependent cancer growth

August 8, 2023 AKT, cancer growth, lung cancer, MAPK4, PDK1, Prostate Cancer, Research, triple-negative breast cancer

This study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.

From The Labs

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

June 8, 2023 Breast Cancer, cancer treatment, Prostate Cancer, Research, SRC-3, Tregs, tumor microenvironment

The findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.

A microscopic view of prostate cancer. It appears as a field of hazy pink and white with splotches of purple indicating cancer cells.

From The Labs

A novel strategy to suppress prostate cancer growth

October 26, 2022 androgen receptor, castration therapy, COP1, Gata2, Prostate Cancer, Research, treatment resistance

The researchers took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy.

From The Labs

The bone microenvironment ‘empowers’ cancer cells to become metastatic

May 18, 2021 bone microenvironment, Breast Cancer, EZH2, Metastasis, Prostate Cancer, Research

The bone microenvironment prompts changes in breast cancer cells that help them escape treatment and become more invasive.

From The Labs

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021 Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

From The Labs

The N-terminal domain of the androgen receptor is at the heart of its action

July 30, 2020 androgen receptor, C-terminal domain, coactivators, n-terminal domain, Prostate Cancer, Research, testosterone

Detailed 3-D studies reveal how the androgen receptor is put together as a functional complex that drives prostate cancer.

From The Labs

Making ‘sense’ of the ‘cart before the horse’ in mammalian cells

January 22, 2019 antisense RNA, Cancer, fusion DNA, fusion RNA, Prostate Cancer, Research, sense RNA

A fusion gene is a new gene made by joining parts of two different genes. The current thought is that fusion genes can happen in

From The Labs

2017 Michael E. DeBakey M.D. Award for Research Excellence

May 26, 2017 2017 DeBakey Award for Research Excellence, Breast Cancer, Cardiothoracic Surgery, DeBakey award, endocrine cancer, gene regulation, Neuroscience, NK cells, Norovirus, Primary immunodeficiencies, Prostate Cancer, rotavirus

The five winners of this year’s Michael E. DeBakey M.D. Award for Research Excellence exemplify the breadth and depth of scientific research at Baylor College

From The Labs

New oncogene MNX1 contributes to higher incidence of prostate cancer among African American men

October 12, 2016 African American men, AKT, lipid metabolism, oncogene MNX1, Prostate Cancer, testosterone

Genetic factors can explain, at last in part, the higher incidence of prostate cancer among African American men compared with men of other ethnic groups.

← Previous